TTRX — Turn Therapeutics Inc. Common Stock

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $10.43 Analyst target: $25.00 Upside: 139.69%

About Turn Therapeutics Inc. Common Stock

Turn Therapeutics Inc., is a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company is headquartered in Westlake Village, California.

See the full interactive analysis & chart →

Informational only — not investment advice.